Highbridge Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Highbridge Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-16,500	Closed	-$859K	–	1888
2015 Q2	$859K	Buy	16,500 +4,300	+35%	+$214K	0.01%	774
2015 Q1	$567K	Sell	12,200 -18,300	-60%	-$950K	0.01%	926
2014 Q4	$1.37M	Sell	30,500 -64,000	-68%	-$2.69M	0.02%	564
2014 Q3	$3.68M	Buy	+94,500	New	+$3.71M	0.05%	352

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Highbridge Capital Management's ISEE Position: Q4 2016 in Review

Highbridge Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 4,925 shares — an estimated $227K sold.

Highbridge Capital Management first reported a position in ISEE in Q2 2014 and held it in 6 quarters. The position peaked at $6.45M in Q3 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

Highbridge Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Highbridge Capital Management sold 4,925 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $227K.
Highbridge Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 6 quarters.
Highbridge Capital Management's IVERIC bio, Inc. Common Stock position peaked at $6.45M in Q3 2015.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.